Theravance Biopharma Inc (TBPH)
9.21
-0.32
(-3.36%)
USD |
NASDAQ |
Apr 18, 16:00
9.21
0.00 (0.00%)
After-Hours: 20:00
Theravance Biopharma Net Income (TTM): -55.19M for Dec. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -55.19M |
September 30, 2023 | -57.04M |
June 30, 2023 | 868.54M |
March 31, 2023 | 875.99M |
December 31, 2022 | 872.13M |
September 30, 2022 | 850.46M |
June 30, 2022 | -101.48M |
March 31, 2022 | -145.69M |
December 31, 2021 | -199.43M |
September 30, 2021 | -225.83M |
June 30, 2021 | -264.16M |
March 31, 2021 | -274.64M |
December 31, 2020 | -278.02M |
September 30, 2020 | -285.19M |
June 30, 2020 | -269.98M |
March 31, 2020 | -246.93M |
December 31, 2019 | -236.46M |
September 30, 2019 | -221.04M |
June 30, 2019 | -222.04M |
March 31, 2019 | -223.02M |
December 31, 2018 | -215.52M |
Date | Value |
---|---|
September 30, 2018 | -252.26M |
June 30, 2018 | -259.70M |
March 31, 2018 | -285.17M |
December 31, 2017 | -285.40M |
September 30, 2017 | -265.82M |
June 30, 2017 | -232.90M |
March 31, 2017 | -213.84M |
December 31, 2016 | -190.67M |
September 30, 2016 | -168.16M |
June 30, 2016 | -181.52M |
March 31, 2016 | -181.89M |
December 31, 2015 | -182.22M |
September 30, 2015 | -201.70M |
June 30, 2015 | -208.88M |
March 31, 2015 | -219.49M |
December 31, 2014 | -237.04M |
September 30, 2014 | -216.81M |
June 30, 2014 | -203.39M |
March 31, 2014 | -184.13M |
December 31, 2013 | -156.28M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-285.19M
Minimum
Sep 2020
875.99M
Maximum
Mar 2023
20.21M
Average
-221.04M
Median
Sep 2019
Net Income (TTM) Benchmarks
Corcept Therapeutics Inc | 106.14M |
Nektar Therapeutics | -276.06M |
Vanda Pharmaceuticals Inc | 2.509M |
Fate Therapeutics Inc | -160.93M |
FibroGen Inc | -284.23M |